Biohit Oyj

HEL:BIOBV.HE

1.95 (EUR) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 13.07610.9519.3617.12310.0529.9318.9798.1956.0514.3633.4522.04839.92240.04435.36634.80532.75131.40828.6626.702
Cost of Revenue 9.13.843.4473.1653.3853.493.3393.992.8541.9241.7011.329.5848.2036.4716.6816.6976.4255.6835.578
Gross Profit 3.9767.1115.9143.9586.6676.4415.644.2053.1972.4391.7510.72830.33831.84128.89528.12426.05424.98322.97721.124
Gross Profit Ratio 0.3040.6490.6320.5560.6630.6490.6280.5130.5280.5590.5070.3550.760.7950.8170.8080.7960.7950.8020.791
Reseach & Development Expenses 1.1731.2381.1661.0431.2321.291.21.9682.0382.0671.0630.9700000000
General & Administrative Expenses 01.0081.2421.0261.1481.1891.1380.8860.4720.9172.270.780000-1.95-2.05600
Selling & Marketing Expenses 0.5440.4480.5110.5930.8570.9320.4540.9511.1460.9632.3692.17800002.1132.20800
SG&A 0.5441.4561.7531.6192.0052.1211.5921.8371.6181.884.6392.95800000.1630.15200
Other Expenses 1.3794.5265.6625.5146.0736.2825.6743.5673.1012.9971.9081.386-13.92331.33427.42726.81-0.002-0.00223.01120.873
Operating Expenses 6.4595.9827.4157.1338.0788.4037.2667.3726.7576.9447.615.314-13.92331.33427.42726.8126.52825.1323.01120.873
Operating Income 1.8250.862-1.383-3.175-1.374-1.9656.356-3.356-2.9-4.504-5.86-4.58644.2620.5071.191.314-0.458-0.143-0.0330.251
Operating Income Ratio 0.140.079-0.148-0.446-0.137-0.1980.708-0.41-0.479-1.032-1.698-2.2391.1090.0130.0340.038-0.014-0.005-0.0010.009
Total Other Income Expenses Net 0.37-0.2610.078-0.0880.147-0.0580.050.081-0.0030.192-0.0610.92746.033-0.119-0.521-0.318-0.919-0.464-0.223-0.147
Income Before Tax 2.1950.868-1.305-3.261-1.227-2.0246.405-3.275-2.903-4.312-5.921-3.65943.7890.3880.6690.996-1.116-0.607-0.2560.104
Income Before Tax Ratio 0.1680.079-0.139-0.458-0.122-0.2040.713-0.4-0.48-0.988-1.715-1.7871.0970.010.0190.029-0.034-0.019-0.0090.004
Income Tax Expense 0.3440.2670.1950.0510.1890.120.2670.020.0140.105-0.004-0.0046.080.3270.2820.0990.3860.232-0.030.265
Net Income 1.8510.601-1.5-3.312-1.416-2.1436.139-3.295-2.917-1.161-5.917-3.65637.710.0610.3870.897-1.502-0.839-0.226-0.169
Net Income Ratio 0.1420.055-0.16-0.465-0.141-0.2160.684-0.402-0.482-0.266-1.714-1.7850.9450.0020.0110.026-0.046-0.027-0.008-0.006
EPS 0.120.04-0.1-0.22-0.094-0.140.42-0.22-0.2-0.083-0.43-0.272.860.0050.030.07-0.12-0.065-0.018-0.013
EPS Diluted 0.120.04-0.1-0.22-0.094-0.140.41-0.22-0.2-0.08-0.43-0.272.860.0050.030.07-0.11-0.061-0.018-0.013
EBITDA 2.6891.3420.692-1.2510.779-0.1887.413-2.919-2.581-4.059-5.653-3.257-1.3422.5923.283.3821.6791.6191.6691.809
EBITDA Ratio 0.2060.1230.065-0.1870.063-0.0180.018-0.366-0.566-0.944-1.59-1.591.2280.0710.0930.1020.0360.050.0620.072